Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model

American Journal of Ophthalmology ◽

10.1016/s0002-9394(00)00689-9 ◽

2000 ◽

Vol 130 (6) ◽

pp. 717-723 ◽

Author(s):

Peter A Netland ◽

Charles Leahy ◽

Kathleen L Krenzer

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Ophthalmic Suspension

Download Full-text

Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: A single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis

Clinical Therapeutics ◽

10.1016/s0149-2918(08)80051-3 ◽

2008 ◽

Vol 30 (7) ◽

pp. 1272-1282 ◽

Author(s):

Gail L. Torkildsen ◽

Mark B. Abelson ◽

Paul J. Gomes

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Single Center ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model

Clinical Ophthalmology ◽

10.2147/opth.s185835 ◽

2018 ◽

Vol Volume 12 ◽

pp. 2617-2628 ◽

Author(s):

Edward Meier ◽

Gail Torkildsen ◽

Paul Gomes ◽

Mark C. Jasek

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Phase Iii ◽

Phase Iii Trials ◽

Conjunctival Allergen Challenge

Download Full-text

Evaluation of Comfort Using Olopatadine Hydrochloride 0.1% Ophthalmic Solution in the Treatment of Allergic Conjunctivitis in Contact Lens Wearers Compared to Placebo Using the Conjunctival Allergen-Challenge Model

Eye & Contact Lens Science & Clinical Practice ◽

10.1097/01.icl.0000063576.32087.f7 ◽

2003 ◽

Vol 29 (2) ◽

pp. 113-116 ◽

Author(s):

Miguel Brodsky ◽

William E. Berger ◽

Salim Butrus ◽

Arthur B. Epstein ◽

Murat Irkec

Keyword(s):

Contact Lens ◽

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Cornea ◽

10.1097/ico.0000000000000562 ◽

2015 ◽

Vol 34 (10) ◽

pp. 1245-1251 ◽

Author(s):

Eugene McLaurin ◽

Abhijit Narvekar ◽

Paul Gomes ◽

Adeniyi Adewale ◽

Gail Torkildsen

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Efficacy And Safety ◽

Phase 3 ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/s0149-2918(02)80007-8 ◽

2002 ◽

Vol 24 (6) ◽

pp. 918-929 ◽

Author(s):

Gregg J. Berdy ◽

Juan O. Stoppel ◽

Arthur B. Epstein

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Loteprednol Etabonate ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride ◽

Ophthalmic Suspension

Download Full-text

Bepotastine Besilate Ophthalmic Solution 1.5% Produces Strong Clinical Benefit for Ocular Itching Immediately Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2010.12.1021 ◽

2011 ◽

Vol 127 (2) ◽

pp. AB256-AB256

Author(s):

J.C. Clark ◽

J.I. Williams ◽

P.J. Gomes ◽

M.B. Abelson ◽

J.A. Gow ◽

...

Keyword(s):

Clinical Benefit ◽

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Ocular Itching ◽

Conjunctival Allergen Challenge

Download Full-text

An Evaluation of Onset and Duration of Action of Patanol® (Olopatadine Hydrochloride Ophthalmic Solution 0.1%) Compared to Claritin® (Loratadine 10 mg) Tablets in Acute Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model

Acta Ophthalmologica Scandinavica ◽

10.1034/j.1600-0420.2000.078s230060.x ◽

2000 ◽

Vol 78 ◽

pp. 60-63 ◽

Author(s):

Mark B. Abelson ◽

Donna L. Welch

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Duration Of Action ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Efficacy of Levocabastine Hydrochloride Ophthalmic Suspension in the Conjunctival Allergen Challenge Test in Japanese Subjects with Seasonal Allergic Conjunctivitis

Allergology International ◽

10.2332/allergolint.55.157 ◽

2006 ◽

Vol 55 (2) ◽

pp. 157-165 ◽

Author(s):

Etsuko Takamura ◽

Keiko Nomura ◽

Hiroshi Fujishima ◽

Kazumi Fukagawa ◽

Yoshiyuki Satake ◽

...

Keyword(s):

Allergic Conjunctivitis ◽

Challenge Test ◽

Allergen Challenge ◽

Seasonal Allergic Conjunctivitis ◽

Conjunctival Allergen Challenge ◽

Japanese Subjects ◽

Ophthalmic Suspension

Download Full-text

Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model

Current Medical Research and Opinion ◽

10.1185/030079904x5724 ◽

2004 ◽

Vol 20 (12) ◽

pp. 1953-1958 ◽

Author(s):

Mark B. Abelson ◽

Jack V. Greiner

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Comparative Efficacy ◽

Solution Versus ◽

Conjunctival Allergen Challenge ◽

Ophthalmic Suspension

Download Full-text

Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Tearing 16 Hours Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2010.12.1022 ◽

2011 ◽

Vol 127 (2) ◽

pp. AB257-AB257

Author(s):

J.I. Williams ◽

E.B. McLaurin ◽

F.K. Kurata ◽

M.B. Abelson ◽

J.A. Gow ◽

...

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge

Download Full-text